Pharma · Private company
Roche-Genentech
Track this companyFree. Adds Roche-Genentech to your Dealase workspace and tells you when its record changes.
Clinical trials219 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials21
- Effect of Omalizumab in the Skin of Food Allergy PatientsPHASE4 · RECRUITING · started Oct 1, 2024ClinicalTrials.gov NCT06618963 · fetched Nov 12, 2026
- Spinal Cord Stimulation for the Treatment of Motor Deficits in People With Spinal Muscular Atrophy - Upper LimbNA · COMPLETED · started May 31, 2024ClinicalTrials.gov NCT06300996 · fetched Nov 12, 2026
- P-CD19CD20-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With B Cell MalignanciesPHASE1 · ACTIVE_NOT_RECRUITING · started Apr 16, 2024ClinicalTrials.gov NCT06014762 · fetched Nov 12, 2026
- Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)PHASE3 · ACTIVE_NOT_RECRUITING · started Oct 1, 2022ClinicalTrials.gov NCT05183035 · fetched Nov 12, 2026
- Identifying and Characterizing Preclinical MSRECRUITING · started Jun 21, 2022ClinicalTrials.gov NCT05787795 · fetched Nov 12, 2026
- P-BCMA-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Multiple MyelomaPHASE1 · ACTIVE_NOT_RECRUITING · started May 5, 2022ClinicalTrials.gov NCT04960579 · fetched Nov 12, 2026
- Spinal Cord Stimulation in Spinal Muscular AtrophyNA · COMPLETED · started Apr 5, 2022ClinicalTrials.gov NCT05430113 · fetched Nov 12, 2026
- Study to Assess Adverse Events and the Movement of Oral Venetoclax Tablet Through the Body of Female Participants Aged 18-75 Years With Impaired Renal FunctionPHASE1 · COMPLETED · started Jul 8, 2021ClinicalTrials.gov NCT04810598 · fetched Nov 12, 2026
- Avo In R/R And Previously Untreated MCLPHASE1_PHASE2 · RECRUITING · started Jul 2, 2021ClinicalTrials.gov NCT04855695 · fetched Nov 12, 2026
- Study of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPCPHASE3 · ACTIVE_NOT_RECRUITING · started Oct 19, 2020ClinicalTrials.gov NCT04446117 · fetched Nov 12, 2026
- A Study of Oral Venetoclax Tablets and Oral Azacitidine as Maintenance Therapy in Adult Participants With Acute Myeloid Leukemia in First Remission After Conventional ChemotherapyPHASE3 · COMPLETED · started Mar 26, 2020ClinicalTrials.gov NCT04102020 · fetched Nov 12, 2026
- Study of Zanubrutinib, Obinutuzumab, and Venetoclax in Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL)PHASE2 · ACTIVE_NOT_RECRUITING · started Feb 22, 2019ClinicalTrials.gov NCT03824483 · fetched Nov 12, 2026
- Tocilizumab Plus a Short Prednisone Taper for GCAPHASE4 · COMPLETED · started Nov 28, 2018ClinicalTrials.gov NCT03726749 · fetched Nov 12, 2026
- A Study Designed to Evaluate the Safety and Efficacy of Venetoclax Plus Dexamethasone (VenDex) Compared With Pomalidomide Plus Dexamethasone (PomDex) in Participants With t(11;14)-Positive Relapsed or Refractory Multiple Myeloma.PHASE3 · ACTIVE_NOT_RECRUITING · started Oct 22, 2018ClinicalTrials.gov NCT03539744 · fetched Nov 12, 2026
- Study of Talimogene Laherparepvec With Atezolizumab for Triple Negative Breast Cancer and Colorectal Cancer With Liver MetastasesPHASE1 · COMPLETED · started Mar 19, 2018ClinicalTrials.gov NCT03256344 · fetched Nov 12, 2026
- A Study of the Safety and Pharmacokinetics of Venetoclax in Pediatric and Young Adult Patients With Relapsed or Refractory MalignanciesPHASE1 · COMPLETED · started Nov 8, 2017ClinicalTrials.gov NCT03236857 · fetched Nov 12, 2026
- Atezolizumab With Bevacizumab in Previously Untreated Metastatic/Unresectable Urothelial CancerPHASE2 · TERMINATED · started Sep 13, 2017ClinicalTrials.gov NCT03272217 · fetched Nov 12, 2026
- Carboplatin, Etoposide, and Atezolizumab With or Without Trilaciclib (G1T28), a CDK4/6 Inhibitor, in Extensive-Stage SCLCPHASE2 · COMPLETED · started Jun 29, 2017ClinicalTrials.gov NCT03041311 · fetched Nov 12, 2026
- A Trial of Atezolizumab and Vigil in Patients With Advanced Gynecological CancersPHASE2 · COMPLETED · started May 31, 2017ClinicalTrials.gov NCT03073525 · fetched Nov 12, 2026
- Obinutuzumab in cGVHD After Allogeneic Peripheral Blood Stem Cell TransplantationPHASE2 · COMPLETED · started Nov 29, 2016ClinicalTrials.gov NCT02867384 · fetched Nov 12, 2026
- A Phase 2 Open-Label Study of the Efficacy and Safety of ABT-199 (GDC-0199) in Chronic Lymphocytic Leukemia (CLL) Subjects With Relapse or Refractory to B-Cell Receptor Signaling Pathway Inhibitor TherapyPHASE2 · COMPLETED · started Sep 10, 2014ClinicalTrials.gov NCT02141282 · fetched Nov 12, 2026